Stocksigma LogoStocksigma Logo

Godavari Drugs Director Ghanshyam Jaju Converts 60,000 Warrants into Equity Shares

Godavari Drugs Ltd disclosed that director and promoter Ghanshyam Jaju acquired 60,000 equity shares on 17th Nov'26 via the conversion of 60,000

Godavari Drugs Director Ghanshyam Jaju Converts 60,000 Warrants into Equity Shares

Godavari Drugs Ltd 路 Acquisition/ Disposal of Shares 路 17 Nov 2026, 9:57 pm

Godavari Drugs Director Ghanshyam Jaju Converts 60,000 Warrants into Equity Shares Godavari Drugs Ltd disclosed that director and promoter Ghanshyam Jaju acquired 60,000 equity shares on 17th Nov'26 via the conversion of 60,000 convertible warrants. Following the allotment, Jaju's direct equity holding increased from 4,10,000 shares (3.76% of pre-allotment voting capital) to 4,70,000 shares, representing 4.02% of the expanded voting capital of Rs 11.70 cr. His remaining convertible warrants stand at 60,000, bringing his total post-acquisition holding of shares and convertible instruments to 5,30,000 units (4.24% of diluted voting capital).

Original exchange filing (PDF)

More announcements from Godavari Drugs Ltd

All Godavari Drugs Ltd announcements